A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis
Clinical trial NCT00087529 · COMPLETED
Trial details
- NCT number
- NCT00087529
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2007-10-01
- Enrollment
- 439
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.